Federal regulators should take care not to disrupt the supply of opioids for patients with legitimate needs as they amend rules that govern quotas for controlled substances, industry groups said in comments submitted to the Drug Enforcement Administration.   DEA on April 19 proposed to alter the quota management system for producing, manufacturing and procuring controlled substanc... Read More